Max Healthcare Institute Ltd. has announced a strategic foray into Bhubaneswar, Odisha, by acquiring a 58.39% controlling stake in Kalinga Hospital Ltd. for an equity value of ₹300 crore. This 250-bed facility expansion, supported by ₹100 crore in dedicated infrastructure investment and ₹300 crore in external commercial borrowings, marks a significant milestone in the company’s mission to strengthen its healthcare network and service footprint across Eastern India.
Acquisition Overview
In a major move to expand its presence in Eastern India, Max Healthcare has entered into a definitive share purchase agreement to acquire a 58.39% controlling stake in Kalinga Hospital Ltd. (KHL). The acquisition is valued at an equity value of ₹300 crore. Kalinga Hospital, established in 1997, is a well-regarded 250-bed facility located in Bhubaneswar, Odisha, that provides comprehensive super-specialty services.
Infrastructure and Financial Commitment
To support the hospital’s growth, Max Healthcare has committed an additional ₹100 crore toward construction, renovation, and the modernization of medical equipment. Furthermore, the board has approved a $5 million corporate guarantee to facilitate the re-financing of the existing promoter’s debt. The acquisition itself is being financed through a ₹300 crore senior secured term loan in the form of external commercial borrowings from Standard Chartered Bank.
Strategic Rationale and Growth Potential
The facility sits on a 10-acre campus with significant brownfield potential. Max Healthcare plans to leverage the hospital’s prime location in Maitri Vihar, Bhubaneswar, to address the region’s surging demand for high-quality, multidisciplinary care. With an existing built-up area of 2,60,000 sq. ft., the site offers immense long-term expansion capacity, with the potential to reach over 1,000 beds in the future.
Board and Leadership Updates
Alongside the acquisition news, the company has confirmed the re-appointment of Mr. Narayan K. Seshadri as a Non-Executive and Non-Independent Director. His tenure has been extended for a further 3 years, effective from May 16, 2026, to May 15, 2029. Mr. Seshadri brings over four decades of deep strategic and financial expertise to the board, further strengthening the company’s governance as it embarks on this new phase of geographic expansion.
Source: BSE
